Virosomal influenza vaccine

BIOLOGICAL3 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, Crucell Holland BV

Conditions

ImmunosuppressionInfluenza

Phase 1

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

CompletedNCT01617239

Crucell Holland BVInfluenza

Start: 2012-06-30End: 2013-12-31Updated: 2014-08-20

Phase 4

Influenza Vaccination in Immunocompromized Patients

CompletedNCT00783380

Insel Gruppe AG, University Hospital BernImmunosuppression

Start: 2005-10-31End: 2008-03-31Updated: 2008-11-03

Unknown Phase

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

CompletedNCT01631071

Crucell Holland BVInfluenza

Start: 2012-07-31End: 2012-08-31Updated: 2013-12-20

Related Papers

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.

2009-05-0164 citations